Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · IEX Real-Time Price · USD
16.80
+1.01 (6.40%)
Mar 28, 2024, 11:54 AM EDT - Market open

DAWN Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Cash & Equivalents
230.7885.26284.3143.7327.33
Short-Term Investments
135.56257.01000
Cash & Cash Equivalents
366.35342.27284.3143.7327.33
Cash Growth
7.03%20.39%550.18%59.99%-
Other Current Assets
8.935.615.061.340.01
Total Current Assets
375.27347.87289.3745.0727.34
Property, Plant & Equipment
0.560.720.280.480
Other Long-Term Assets
0.210.470.170.110
Total Long-Term Assets
0.771.190.450.590
Total Assets
376.05349.06289.8245.6627.34
Accounts Payable
2.580.261.740.20.07
Current Debt
0.410.410.20.20
Other Current Liabilities
26.5215.956.711.61.95
Total Current Liabilities
29.5116.628.6622.02
Long-Term Debt
00.410.020.20
Total Long-Term Liabilities
00.410.020.20
Total Liabilities
29.5117.028.672.22.02
Total Debt
0.410.810.220.40
Debt Growth
-49.82%269.55%-45.27%--
Retained Earnings
-458.59-269.67-127.49-56.84-12.78
Comprehensive Income
0.01-0.07000
Shareholders' Equity
346.54332.04281.15-54.21-10.67
Net Cash / Debt
365.94341.46284.0943.3327.33
Net Cash / Debt Growth
7.17%20.19%555.70%58.52%-
Net Cash Per Share
4.595.227.697.844.61
Working Capital
345.77331.26280.7143.0825.32
Book Value Per Share
4.345.077.61-9.80-1.80
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).